Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin
- PMID: 7492114
- PMCID: PMC162791
- DOI: 10.1128/AAC.39.7.1606
Activities of three investigational fluoroquinolones (BAY y 3118, DU-6859a, and clinafloxacin) against Neisseria gonorrhoeae isolates with diminished susceptibilities to ciprofloxacin and ofloxacin
Abstract
Between 1 January 1992 and 31 December 1993, our laboratory, as part of the Gonococcal Isolate Surveillance Project, found that 39 of 673 isolates of Neisseria gonorrhoeae from one local sexually transmitted diseases clinic demonstrated decreased susceptibilities to both ciprofloxacin and ofloxacin. The MICs of BAY y 3118, DU-6859a, and clinafloxacin at which 90% of the gonococci with decreased susceptibility to ciprofloxacin and ofloxacin were inhibited were all 0.016 microgram/ml, which was eightfold higher than those for ciprofloxacin-susceptible gonococci. Our report substantiates prior observations that diminished susceptibility to one quinolone is often associated with diminished susceptibility to other quinolones.
Similar articles
-
Cross-resistance analysis for DU-6859a, a new fluoroquinolone, compared to six structurally similar compounds (ciprofloxacin, clinafloxacin, fleroxacin, levofloxacin, ofloxacin, and sparfloxacin).Diagn Microbiol Infect Dis. 1995 Jan;21(1):51-4. doi: 10.1016/0732-8893(94)00116-e. Diagn Microbiol Infect Dis. 1995. PMID: 7789097
-
Antimicrobial susceptibilities of strains of Neisseria gonorrhoeae in Bangkok, Thailand: 1994-1995.Sex Transm Dis. 1997 Mar;24(3):142-8. doi: 10.1097/00007435-199703000-00004. Sex Transm Dis. 1997. PMID: 9132980
-
Antibacterial activities of OPC-17116, ofloxacin, and ciprofloxacin against 200 isolates of Neisseria gonorrhoeae.Antimicrob Agents Chemother. 1993 Oct;37(10):2244-6. doi: 10.1128/AAC.37.10.2244. Antimicrob Agents Chemother. 1993. PMID: 8257153 Free PMC article.
-
Decreased susceptibility of Neisseria gonorrhoeae to fluoroquinolones--Ohio and Hawaii, 1992-1994.MMWR Morb Mortal Wkly Rep. 1994 May 13;43(18):325-7. MMWR Morb Mortal Wkly Rep. 1994. PMID: 8164636
-
Proposed criteria for interpretation of susceptibilities of strains of Neisseria gonorrhoeae to ciprofloxacin, ofloxacin, enoxacin, lomefloxacin, and norfloxacin.Antimicrob Agents Chemother. 1995 Nov;39(11):2442-5. doi: 10.1128/AAC.39.11.2442. Antimicrob Agents Chemother. 1995. PMID: 8585723 Free PMC article.
Cited by
-
Concurrent gonococcal and chlamydial infection: how best to treat.Drugs. 2000 Apr;59(4):801-13. doi: 10.2165/00003495-200059040-00006. Drugs. 2000. PMID: 10804036 Review.
-
In vitro activities of clinafloxacin against contemporary clinical bacterial isolates from 10 North American centers.Antimicrob Agents Chemother. 1998 May;42(5):1274-7. doi: 10.1128/AAC.42.5.1274. Antimicrob Agents Chemother. 1998. PMID: 9593166 Free PMC article.
-
DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance.Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13991-6. doi: 10.1073/pnas.94.25.13991. Proc Natl Acad Sci U S A. 1997. PMID: 9391140 Free PMC article.
-
Quinolones in sexually transmitted diseases: state of the art.Drugs. 1999;58 Suppl 2:92-5. doi: 10.2165/00003495-199958002-00018. Drugs. 1999. PMID: 10553714 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources